InvestorsHub Logo

HMB2010

11/04/21 10:32 AM

#334761 RE: nidan7500 #334757

Conveniently included "In October 2021, a second Citizen Petition was submitted to FDA by an individual unknown to Cassava Sciences. This second petitioner “is requesting the FDA for approval of simufilam and immediate initiation of Phase 4 trials for further efficacy, safety assessment and, most critically, to address one of the greatest needs in modern medicine.”

"FDA has not engaged with the Company regarding either Citizen Petition."

https://www.cassavasciences.com/news-releases/news-release-details/review-journal-neuroscience-shows-no-evidence-data-manipulation

Some may get burned badly thinking its a done deal but Anavex will prevail, imo.